A Study of Neladalkib (NVL-655) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ALK Rearrangement or Activating ALK Mutation (ALKOVE-1)
for Locally Advanced Solid Tumor
21 locations incl. Orange
Sponsor: Nuvalent Inc.
Sex: All·Age: 12+
Code: NCT05384626·Phase 1, Phase 2·Recruiting